Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

4.76
Delayed Data
As of 3:59pm ET
 -0.05 / -1.04%
Today’s Change
2.47
Today|||52-Week Range
8.20
+33.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$53.1M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its patented technology enables the commercial-scale production of central nervous system stem cells. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:
(301) 366-1481

Employees

Shareholders

Mutual fund holders5.46%
Individual stakeholders1.34%
Other institutional-0.02%

Top Executives

Richard J. DalyChairman, President & Chief Executive Officer
Jonathan B. Lloyd JonesChief Financial Officer
Karl Y. JoheChief Scientific Officer
Thomas HazelSenior Vice President-Research
Danielle SpanglerInvestor Relations Contact